Adherence
Higher total daily sedentary time is independently associated with increased cancer mortality risk in middle-aged and older adults, regardless of moderate-to-vigorous physical activity (MVPA) levels.
If you are over 45, your total daily sitting time matters for your long-term survival risk, independent of how much you exercise. Use an accelerometer or pedometer to track total sedentary minutes. Aim to reduce total sitting time, not just to 'get your workout in,' but to lower your baseline risk profile.
In multivariable-adjusted models, including MVPA, greater total sedentary time was associated with a greater risk of cancer mortality (tertile 2 vs tertile 1: hazard ratio [HR], 1.45; 95% CI, 1.00-2.11; tertile 3 vs tertile 1: HR, 1.52; 95% CI, 1.01-2.27).
Why this rating
Prospective cohort study with objective accelerometer measurement and large sample size (n=8002), though observational design limits causal inference.
Source
Association of Sedentary Behavior With Cancer Mortality in Middle-aged and Older US Adults
Susan C. Gilchrist et al. · JAMA Oncology · 2020
DOI 10.1001/jamaoncol.2020.2045
More from this paper
- Replacing 30 minutes of sedentary time with moderate-to-vigorous physical activity (MVPA) significantly reduces cancer mortality risk by 31%, while replacing it with light-intensity physical activity (LIPA) reduces risk by 8%.Good
- The duration of uninterrupted sedentary bouts (prolonged sitting) is not significantly associated with cancer mortality risk after adjusting for MVPA and other covariates.Good
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →